Enterprise League logo

Product

IN-006

BIOTECHNOLOGY

byInhalon Biopharma

United States (US)

ABOUT THE PRODUCT

IN-006 is an inhaled antibody treatment designed to trap pathogens in the lung mucus, blocking their spread and facilitating their rapid elimination. It is currently in Phase 1b clinical trials for the treatment of COVID-19.

Information is owner-confirmed

Last updated 1 week ago

Price range
N/A

Other products/services from Inhalon Biopharma